Clinical Trials Browser

Recruiting × OTHER × Radiotherapy × Clear all

NCT02468024 2026-03-18

STABLE-MATES

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT05941741 2026-03-18

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Phase 3 Recruiting

Nasopharyngeal Carcinoma

NCT04732065 2026-03-17

PNOC023

Phase 1 Recruiting

Ependymoma, Glioblastoma, Central Nervous System Neoplasms

NCT06934889 2026-03-17

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

Phase 1 Recruiting

Glioblastoma, Gliosarcoma

NCT07282483 2026-03-17

Traditional Chinese Medicine Oral Liquids and Mouthwashes for Radiation-induced Oral Mucositis in Head and Neck Cancer Patients

Phase 2 Recruiting

Radiation-induced Oral Mucositis

NCT05950594 2026-03-16

IVIM & OLINK in Sarcoma

Phase 2 Recruiting

Sarcoma

NCT07245745 2026-03-16

Prospective Clinical Study Comparing PROMS After Adaptive or Conventional Radiotherapy in Prostate Cancer

Phase NA Recruiting

Prostatic Neoplasms

NCT03875716 2026-03-13

Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma

Phase NA Recruiting

Head and Neck Neoplasms

NCT02287428 2026-03-12

Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

Phase 1 Recruiting

Glioblastoma

NCT03968406 2026-03-11

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

Phase 1 Recruiting

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Endometrial Neoplasms

NCT06504381 2026-03-11

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

Phase 1/2 Recruiting

Glioma

NCT06954623 2026-03-10

BREAST

Phase NA Recruiting

Breast Neoplasms

NCT05986318 2026-03-09

RESPIRE-ILD

Phase 2 Recruiting

Lung Neoplasms, Lung Diseases, Interstitial, Radiation Pneumonitis

NCT06483308 2026-03-09

SHiP-Rt

Phase NA Recruiting

Lung Neoplasms

NCT04075305 2026-03-05

MOMENTUM

BreastCNSGastrointestinalGenitourinaryHead & NeckThoracic

Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Genital Neoplasms, Female, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Radiation Injuries, Rectal Neoplasms

NCT04170946 2026-03-05

Talazoparib

Phase 1 Recruiting

Lung Neoplasms, Small Cell Lung Carcinoma

NCT04857528 2026-03-04

Detecting HPV DNA in Anal and Cervical Cancers

GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms

NCT06823375 2026-03-04

SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis

Phase 2 Recruiting

HCC

NCT06950073 2026-03-04

CureLung

Lung Neoplasms, Neoplasms, Radiation Injuries

NCT06992427 2026-03-04

HOPE

Phase 3 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT07448142 2026-03-04

Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT06208826 2026-03-03

A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy

Phase 2 Recruiting

Head and Neck Neoplasms

NCT06719700 2026-03-03

Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer

Phase 2 Recruiting

Small Cell Lung Carcinoma

NCT06434350 2026-03-02

Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE)

Phase 1/2 Recruiting

Advanced Bladder Cancer

NCT07026474 2026-03-02

RePaIr-HN

Phase 3 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT06558981 2026-02-27

Adjuvant Radiotherapy in High Risk Locally Advanced DTC

Phase 3 Recruiting

Thyroid Neoplasms

NCT06719440 2026-02-27

BELGICA

Phase NA Recruiting

Glioblastoma, Radiation Injuries

NCT07039162 2026-02-27

Study of Tislelizumab Combined With Chemoradiotherapy and Surgery for Unresectable Esophageal Squamous Cell Carcinoma

Phase 2 Recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT07053085 2026-02-27

A Study of Surgery and Radiotherapy in People With Breast Cancer

Phase 2 Recruiting

Breast Neoplasms

NCT04947254 2026-02-19

Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer

Phase 2 Recruiting

Prostatic Neoplasms

NCT06859801 2026-02-19

TRIBUTE

Bone Cancer Metastatic

NCT05268614 2026-02-18

Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT04594187 2026-02-17

MelPORT

Phase 2 Recruiting

Melanoma

NCT04983095 2026-02-17

METRO

Phase NA Recruiting

Prostate Cancer Metastatic

NCT06651697 2026-02-17

BEFORE

Phase 3 Recruiting

Pelvic Neoplasms

NCT03861676 2026-02-13

Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT

Phase EARLY_PHASE1 Recruiting

Prostatic Neoplasms

NCT05535166 2026-02-12

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

Phase 2 Recruiting

Brain Neoplasms, Medulloblastoma

NCT06678269 2026-02-12

A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer

Phase 1 Recruiting

Breast Neoplasms

NCT06135714 2026-02-11

OLIGAMI

Phase 3 Recruiting

Breast Neoplasms

NCT06964568 2026-02-10

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

Phase 3 Recruiting

Gastrointestinal

Esophageal Neoplasms

NCT06129747 2026-02-09

Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast

Phase 2 Recruiting

Breast Neoplasms, Neoplasms

NCT06610734 2026-02-09

SKY

Phase 2 Recruiting

Small Cell Lung Cancer Extensive Stage

NCT06834152 2026-02-09

X-SMILE

Adenocarcinoma, Prostatic Hyperplasia, Prostatic Neoplasms, Lower Urinary Tract Symptoms

NCT05039632 2026-02-06

Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies

Phase 1/2 Recruiting

Neoplasm Metastasis

NCT04879940 2026-02-05

Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization

Phase 2 Recruiting

Prostatic Hyperplasia, Prostatic Neoplasms

NCT05476939 2026-02-05

BIOMEDE 2

Phase 3 Recruiting

Diffuse Intrinsic Pontine Glioma

NCT05962242 2026-02-05

HN001

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT07202247 2026-02-04

Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial

Phase 2 Recruiting

Prostatic Neoplasms

NCT05331521 2026-02-03

ImproveCodel

Phase 3 Recruiting

Oligodendroglioma

NCT04754321 2026-02-02

Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer

Phase 1 Recruiting

Squamous Cell Carcinoma of Head and Neck